Medicamen Organics Ltd vs Supriya Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Medicamen Organics Ltd is ₹ 19.4 as of 12 Jun 15:30 . The P/E Ratio of Medicamen Organics Ltd is 0 as of March 2024 .The P/E Ratio of Supriya Lifescience Ltd is 0 as of March 2024 . The Market Cap of Medicamen Organics Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Supriya Lifescience Ltd is ₹ 0 crore as of March 2024 . The revenue of Medicamen Organics Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Supriya Lifescience Ltd for the Mar '26 is ₹ 280.01 crore as compare to the Dec '25 revenue of ₹ 209.05 crore. This represent the growth of 33.94% The ebitda of Medicamen Organics Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Supriya Lifescience Ltd for the Mar '26 is ₹ 101.1 crore as compare to the Dec '25 ebitda of ₹ 74.24 crore. This represent the growth of 36.18% The net profit of Medicamen Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Supriya Lifescience Ltd changed from ₹ 44.64 crore to ₹ 74.23 crore over 8 quarters. This represents a CAGR of 28.95% The Dividend Payout of Medicamen Organics Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 years .

About Medicamen Organics Ltd

Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana.
Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer.
The product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS).

About Supriya Lifescience Ltd

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

FAQs for the comparison of Medicamen Organics Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, Medicamen Organics Ltd or Supriya Lifescience Ltd?

Market cap of Medicamen Organics Ltd is 23 Cr while Market cap of Supriya Lifescience Ltd is 7,876 Cr

What are the key factors driving the stock performance of Medicamen Organics Ltd and Supriya Lifescience Ltd?

The stock performance of Medicamen Organics Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Organics Ltd and Supriya Lifescience Ltd?

As of June 15, 2026, the Medicamen Organics Ltd stock price is INR ₹19.4. On the other hand, Supriya Lifescience Ltd stock price is INR ₹978.65.

How do dividend payouts of Medicamen Organics Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of Medicamen Organics Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.